Capdeville R - Search Results

1

The successful treatment of two cases of severe aplastic anaemia with granulocyte-colony stimulating factor and cyclosporine A.

Bertrand Y, Amri F, Capdeville R, Ffrench M, Philippe N. Bertrand Y, et al. Among authors: capdeville r. Br J Haematol. 1991 Dec;79(4):648-9. doi: 10.1111/j.1365-2141.1991.tb08096.x. Br J Haematol. 1991. PMID: 1722994 No abstract available.

2

[Acute lymphoblastic leukemia in children: which prognostic factors in 1992?].

Capdeville R, Philippe N. Capdeville R, et al. Pediatrie. 1992;47(4):247-55. Pediatrie. 1992. PMID: 1329007 Review. French.

3

[Cerebrovascular accidents and sickle cell disease].

Castell P, Capdeville R, Bertrand Y, Mardini R, Rousselle C, Turjmann F, Contamin B, Philippe N. Castell P, et al. Among authors: capdeville r. Pediatrie. 1992;47(6):451-4. Pediatrie. 1992. PMID: 1331963 French.

4

[Granulocytic sarcoma (chloroma): rare extramedullary tumors associated with acute non-lymphoblastic leukemia].

Capdeville R, Bertrand Y, Manel AM, Charrin C, Souillet G, Philippe N. Capdeville R, et al. Pediatrie. 1990;45(4):245-50. Pediatrie. 1990. PMID: 2163510 French.

5

Cyclosporin A used to reverse drug resistance increases vincristine neurotoxicity.

Bertrand Y, Capdeville R, Balduck N, Philippe N. Bertrand Y, et al. Among authors: capdeville r. Am J Hematol. 1992 Jun;40(2):158-9. doi: 10.1002/ajh.2830400222. Am J Hematol. 1992. PMID: 1585920 No abstract available.

6

Interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity.

Capdeville R, Mousson B, Bax G, Bertrand Y, Philippe N. Capdeville R, et al. Eur J Clin Pharmacol. 1994;46(4):385-6. doi: 10.1007/BF00194412. Eur J Clin Pharmacol. 1994. PMID: 7957529 Clinical Trial. No abstract available.

7

Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.

de Montalembert M, Belloy M, Bernaudin F, Gouraud F, Capdeville R, Mardini R, Philippe N, Jais JP, Bardakdjian J, Ducrocq R, Maier-Redelsperger M, Elion J, Labie D, Girot R. de Montalembert M, et al. Among authors: capdeville r. J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):313-8. doi: 10.1097/00043426-199707000-00009. J Pediatr Hematol Oncol. 1997. PMID: 9256830 Clinical Trial.

8

TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.

Favrot M, Combaret V, Blay JY, Capdeville R, Zhou DC, Clapisson G, Chouaib S, Franks CR, Philip T. Favrot M, et al. Among authors: capdeville r. Eur Cytokine Netw. 1990 Oct-Nov;1(4):221-7. Eur Cytokine Netw. 1990. PMID: 2104243

9

Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.

Favrot M, Capdeville R, Combaret V, Zhou DC, Clapisson G, Banchereau J, Franks CR, Chouaib S, Blay JY, Philip T. Favrot M, et al. Among authors: capdeville r. Eur Cytokine Netw. 1990 Aug-Sep;1(3):141-7. Eur Cytokine Netw. 1990. PMID: 2129798

10

Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.

Sonneveld P, Burnett A, Vossebeld P, Ben-Am M, Rosenkranz G, Pfister C, Verhoef G, Dekker A, Ossenkoppele G, Ferrant C, Yin L, Gratwohl A, Kovacsovics T, Vellenga E, Capdeville R, Löwenberg B. Sonneveld P, et al. Among authors: capdeville r. Hematol J. 2000;1(6):411-21. doi: 10.1038/sj.thj.6200050. Hematol J. 2000. PMID: 11920222 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters